• Grid View
  • List View
  • PrimaryImage Life Sciences Digital Services 2022 2023 - Life Sciences Digital Services 2022–2023 RadarView™

    Life Sciences Digital Services 2022–2023 RadarView™

    The Life Sciences Digital Services 2022–2023 RadarView™ can help enterprises craft a robust strategy based on industry outlook, best practices, and digital transformation. The report can also aid in identifying the right partners and service providers to accelerate digital adoption. The 93-page report also identifies key service providers and system integrators that can help enterprises in their digital transformation journeys.

    September, 2022

  • MoneyShot Life Sciences Digital Services 2022–2023 - The Prescription for Life Sciences Is Complicated

    The Prescription for Life Sciences Is Complicated

    With the cost of developing new products rising and regulatory oversight increasing, profit margins are shrinking for life sciences companies. In response, they are investing in digital technologies to reduce costs and shorten development cycles. They are also pursuing acquisitions and investments in specialized companies to strengthen their technological capabilities specifically in the R&D and clinical trials phase of the value chain. As this requires a strong integration of domain and technological expertise, life sciences companies are collaborating with service providers in their digital transformation journey. These emerging trends are covered in Avasant’s Life Sciences Digital Services 2022–2023 RadarView™.

    September, 2022

  • RVBadges PrimaryImage LS2021 - Life Sciences Digital Services 2020-2021 RadarView™

    Life Sciences Digital Services 2020-2021 RadarView™

    The Life Sciences Digital 2020-2021 Services RadarView™ report provides information to the relevant enterprises assisting them in charting out their action plan as they digitally transform themselves. This 88-page report also identifies critical global service providers and system integrators that can expedite their transformation journey. Additionally, the report highlights the key trends in the market and Avasant’s view on the road ahead for life sciences companies over the next three years.

    April, 2020